Skip to main content

RETRACTION article

Front. Immunol., 14 May 2024
Sec. Inflammation
Volume 15 - 2024 | https://doi.org/10.3389/fimmu.2024.1429708

Retraction: Platelet-derived exosomal microRNA-25–3p inhibits coronary vascular endothelial cell inflammation through Adam10 via the NF-κB signaling pathway in ApoE-/- mice

This article is a retraction of:

  1. RETRACTED: Platelet-Derived Exosomal MicroRNA-25-3p Inhibits Coronary Vascular Endothelial Cell Inflammation Through Adam10 via the NF-κB Signaling Pathway in ApoE−/− Mice

    1. Read original article
Frontiers Editorial Office* Frontiers Editorial Office*

    A Retraction of the Original Research Article
    Platelet-derived exosomal microRNA-25–3p inhibits coronary vascular endothelial cell inflammation through Adam10 via the NF-κB signaling pathway in ApoE−/− mice

    by Yao Y, Sun W, Sun Q, Jing B, Liu S, Liu X, Shen G, Chen R and Wang H (2019). Front. Immunol. 10:2205. doi: 10.3389/fimmu.2019.02205

    The Publisher retracts the cited article.

    “Following publication, concerns were raised regarding the integrity of the images in the published figures OR regarding the validity of the data presented in the article. The authors failed to provide the raw data or a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns about the validity of the data, and the lack of raw data, the editors no longer have confidence in the findings presented in the article.

    This retraction was approved by the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and had a chance to respond. This communication has been recorded by the publisher.”.

    Citation: Frontiers Editorial Office (2024) Retraction: Platelet-derived exosomal microRNA-25–3p inhibits coronary vascular endothelial cell inflammation through Adam10 via the NF-κB signaling pathway in ApoE-/- mice. Front. Immunol. 15:1429708. doi: 10.3389/fimmu.2024.1429708

    Received: 08 May 2024; Accepted: 08 May 2024;
    Published: 14 May 2024.

    Approved by:

    Frontiers Editorial Office, Frontiers Media SA, Switzerland

    Copyright © 2024 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    *Correspondence: Frontiers Editorial Office, research.integrity@frontiersin.org

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.